title: What is better antiplatelet agent to prevent recurrent stroke?
authors.affiliation: Stroke Service and Vascular Fellowship Program, International Cerebrovascular Translational Clinical Research Training Program (Fogarty International Center and National Institute of Neurologic Disorders and Stroke), Aga Khan University Hospital, Karachi, Pakistan.
authors.forename: Muhammad Faisal
authors.initials: MF
authors.lastname: Wadiwala
authors.forename: Ayeesha Kamran
authors.initials: AK
authors.lastname: Kamal
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects; D001565:Benzoates / Q000008:administration & dosage / Q000009:adverse effects; D002545:Brain Ischemia / Q000178:diet therapy / Q000517:prevention & control; D000077144:Clopidogrel; D004176:Dipyridamole / Q000008:administration & dosage / Q000009:adverse effects; D004311:Double-Blind Method; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology; D000077333:Telmisartan; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin; D000077333:Telmisartan